tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

HGEN

One option delisting on January 8th
The FlyOne option delisting on January 8th
10M ago
HGEN
HGEN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
HGEN Upcoming Earnings Report: What to Expect?
1y ago
HGEN
Humanigen plunges after warning on inability to continue as going concern
PremiumThe Fly
Humanigen plunges after warning on inability to continue as going concern
1y ago
HGEN
Humanigen (NASDAQ:HGEN) Nosedives with Bankruptcy Looming Large
PremiumMarket News
Humanigen (NASDAQ:HGEN) Nosedives with Bankruptcy Looming Large
1y ago
HGEN
Is HGEN a Buy, Before Earnings?
PremiumPre-Earnings
Is HGEN a Buy, Before Earnings?
1y ago
HGEN
Humanigen Inc (HGEN) Q4 Earnings Cheat Sheet
PremiumPre-EarningsHumanigen Inc (HGEN) Q4 Earnings Cheat Sheet
2y ago
HGEN
Humanigen reinstated with a Neutral at Cantor Fitzgerald
Premium
The Fly
Humanigen reinstated with a Neutral at Cantor Fitzgerald
2y ago
HGEN
Humanigen Stock: Why It Crashed and Where It’s Headed
Premium
Stock Analysis & Ideas
Humanigen Stock: Why It Crashed and Where It’s Headed
2y ago
HGEN
Humanigen: Topline Data for Covid-19 Treatment Expected in July; What This Could Mean for the Stock
PremiumStock Analysis & Ideas
Humanigen: Topline Data for Covid-19 Treatment Expected in July; What This Could Mean for the Stock
2y ago
HGEN
Humanigen: A ‘Transformative Year’ Awaits, Says Analyst
PremiumStock Analysis & Ideas
Humanigen: A ‘Transformative Year’ Awaits, Says Analyst
2y ago
HGEN
Insiders Buy These 2 Stocks at Discounted Prices — Analysts Say They Have Over 200% Upside Potential
PremiumStock Analysis & Ideas
Insiders Buy These 2 Stocks at Discounted Prices — Analysts Say They Have Over 200% Upside Potential
3y ago
HGEN
NOTV
Humanigen: New Publication Details Lenzilumab’s Economic Benefits, Says Analyst
PremiumStock Analysis & Ideas
Humanigen: New Publication Details Lenzilumab’s Economic Benefits, Says Analyst
3y ago
HGEN
Why 2022 Holds Hope for Humanigen Stock, According to This Analyst
PremiumStock Analysis & IdeasWhy 2022 Holds Hope for Humanigen Stock, According to This Analyst
3y ago
HGEN
Humanigen: All You Need to Know Right Now
Premium
Stock Analysis & Ideas
Humanigen: All You Need to Know Right Now
3y ago
HGEN
Is Humanigen Stock Due for a Turnaround? Analyst Weighs In
Premium
Stock Analysis & Ideas
Is Humanigen Stock Due for a Turnaround? Analyst Weighs In
3y ago
HGEN
Humanigen Stock to $28? This Analyst Thinks So
PremiumStock Analysis & Ideas
Humanigen Stock to $28? This Analyst Thinks So
3y ago
HGEN
Humanigen: Lenzilumab Could Reach the UK Market in 1Q22, Says Analyst
PremiumStock Analysis & Ideas
Humanigen: Lenzilumab Could Reach the UK Market in 1Q22, Says Analyst
3y ago
HGEN
Has Humanigen Stock Hit Bottom? Oppenheimer Looks for the Silver Lining
PremiumStock Analysis & Ideas
Has Humanigen Stock Hit Bottom? Oppenheimer Looks for the Silver Lining
3y ago
HGEN
Humanigen: Lenz Could Become a $1.45 Billion Drug, if Approved, Says Analyst
PremiumStock Analysis & Ideas
Humanigen: Lenz Could Become a $1.45 Billion Drug, if Approved, Says Analyst
3y ago
HGEN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >